Ann Lee

Overview

Senior executive at Prime Medicine; member of the National Academy of Engineering; contributed to commercialization of 25+ medicines including multiple CAR-T therapies across BMS, Celgene, Juno, Genentech, and Roche. Ann Lee holds a PhD in biomedical engineering and is a member of the National Academy of Engineering, having contributed to the commercialization of over 25 medicines including multiple CAR-T therapies across roles at Bristol-Myers Squibb, Celgene, Juno, Genentech, and Roche. Lee joined Prime Medicine approximately five years ago when the company was only one year old, and built its technical operations team by prioritizing analytical development over process development — unusual in her career — and instituting structured electronic laboratory notebooks. (Segment 1 (00:00-05:00))